Dissemin is shutting down on January 1st, 2025

Published in

American Society for Microbiology, Microbiology Spectrum, 3(4), 2016

DOI: 10.1128/microbiolspec.ei10-0017-2016

Emerging Infections 10, p. 143-161, 2016

DOI: 10.1128/9781555819453.ch8

Links

Tools

Export citation

Search in Google Scholar

Chikungunya Virus: Current Perspectives on a Reemerging Virus

Journal article published in 2016 by Clayton R. Morrison, Kenneth S. Plante ORCID, Mark T. Heise
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Orange circle
Published version: archiving restricted
Data provided by SHERPA/RoMEO

Abstract

ABSTRACT Chikungunya virus (CHIKV) is a mosquito-borne alphavirus in the family Togaviridae that causes outbreaks of debilitating acute and chronic arthralgia in humans. Although historically associated with localized outbreaks in Africa and Asia, recent epidemics in the Indian Ocean region and the Americas have led to the recognition that CHIKV is capable of moving into previously unaffected areas and causing significant levels of human suffering. The severity of CHIKV rheumatic disease, which can severely impact life quality of infected individuals for weeks, months, or even years, combined with the explosive nature of CHIKV outbreaks and its demonstrated ability to quickly spread into new regions, has led to renewed interest in developing strategies for the prevention or treatment of CHIKV-induced disease. Therefore, this chapter briefly discusses the biology of CHIKV and the factors contributing to CHIKV dissemination, while also discussing the pathogenesis of CHIKV-induced disease and summarizing the status of efforts to develop safe and effective therapies and vaccines against CHIKV and related viruses.